Technology | February 22, 2013

Digirad Launches Molecular Breast Imaging Accessory for Expanded Use of Ergo Imaging System

Digirad Molecular Breast Imaging Accessory Ergo Imaging System

February 22, 2013  — Digirad Corporation announced the launch of their Molecular Breast Imaging Accessory for the ergo imaging system, further expanding the clinical flexibility of the ergo imaging system for applications in the area of women’s health, as well as in nuclear medicine where the ergo imaging system is currently used for a wide variety of clinical applications.

The introduction of Digirad’s Molecular Breast Imaging Accessory follows the U.S. Food and Drug Administration (FDA) 510(k) market clearance recently received for expanded use of the ergo Imaging System, which includes indications for use to aid in the evaluation of lesions in the breast and other small body parts. When used for breast imaging, the ergo Imaging System can be used as an adjunct to mammography or other primary breast imaging modalities. 

Digirad Chief Executive Officer Todd Clyde noted that this launch marks another key step in the company’s strategy to expand its imaging technology footprint in the hospital through the use of flexible, portable systems with devices that have expanded diagnostics capabilities.

 “We believe the Molecular Breast Imaging Accessory fills an important market need and is a natural addition to the ergo imaging system,” said Clyde. “Advanced diagnostic modalities are often necessary to help clinicians identify lesions in the breast, and our new Molecular Breast Imaging Accessory provides this capability. It is a cost-effective, non-dedicated option for molecular breast imaging that enhances the clinical capabilities and operational efficiencies of the ergo imaging system.”

Annual mammograms are recommended by the American Cancer Society for women age 40 and older, however, not all breast cancers can be detected by mammography, especially in dense breasts. Accordingly, adjunctive diagnostics such as molecular breast imaging can help physicians spot lesions in dense and complex breast tissue.

The user-friendly design of the ergo Molecular Breast Imaging Accessory includes a specialized breast imaging assembly and breast-mode software to capture all normal mammographic views for direct correlation with the patient’s mammogram.  Additionally, it uses Digirad’s industry-leading solid-state detector technology with an oversized field-of-view to obtain comprehensive, high-contrast images. The open design provides easy access for hands-free breast positioning on patients who can be seated, standing or lying down during the examination.

For more information: www.digirad.com

 

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Overlay Init